Section Arrow
Quote
CATX.NYSE-M
- Perspective Therapeutics
Quotes are at least 15-min delayed:2026/03/10 01:07 EDT
Regular Hours
Last
 5.2
+0.23 (+4.63%)
Day High 
5.275 
Prev. Close
4.97 
1-M High
5.9 
Volume 
1.40M 
Bid
5.15
Ask
5.2
Day Low
4.84 
Open
4.85 
1-M Low
4.37 
Market Cap 
566.15M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.29 
20-SMA 5.15 
50-SMA 3.9 
52-W High 6.16 
52-W Low 1.6 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-1.50/-1.06
Enterprise Value
569.21M
Balance Sheet
Book Value Per Share
2.13
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.09
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ABTAbbott Laboratories112.65+3.09+2.82%29.21PE
BSXBoston Scientific Corp71.9+0.55+0.77%36.78PE
MDTMedtronic plc91.34+0.44+0.48%25.39PE
BFLYButterfly Network3.76+0.11+3.01%-- 
PACBPacific Biosciences of California1.39+0.01+0.72%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotopeLead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.